8 | CONN 32.32 Conn's Inc Stock Charts $CONN Last | chartguy89 | 11/18/2014 12:11:46 AM |
7 | CONN Year to date has changed -58.93% percent. | Jake13 | 11/18/2014 12:10:52 AM |
6 | CONN up +3.11% percent Today $CONN High is at | Lucky Jimmy | 11/17/2014 11:48:24 AM |
5 | CONN 32.15 Conn's Inc is number 76 out of 100 Top | Langan | 11/11/2014 7:15:25 PM |
4 | CONN 31.46 Conn's Inc Stock Charts $CONN Last | chartguy89 | 11/11/2014 2:14:03 AM |
3 | CONN Year to date has changed -60.02% percent. | Jake13 | 11/11/2014 12:53:40 AM |
2 | Latest Conn's Inc (CONN) Headlines The Law | Stock_Tracker | 03/12/2014 7:36:49 PM |
1 | CONN Stock Charts Last: +1.45 Wednesday, February | chartguy89 | 02/26/2014 11:51:04 PM |
Recent Articles
- Algorhythm Holdings Expands Fleet for Revenue Growth in Logistics
- Hour Loop Enhances Supply Chains in Response to High Tariffs
- Terri Casey Joins American Oncology Network as HR Leader
- iTeos Discontinues Belrestotug Development Following Analysis
- Key Decisions from TRESU Investment Holding A/S Annual Meeting
- Atomic Minerals Expands Footprint with New Uranium Acquisition
- Hyundai ADM Bio Shifts Focus to Immunotherapy Combinations
- Nayax Achieves Impressive First Quarter Growth and Expansion
- Salimetrics Enhances Testing Capacity Amid New NIH Guidelines
- Polyrizon Ventures into $3.15B Epilepsy Treatment Innovations
- American Tungsten Corp. Announces Upcoming CEO Webinar Event
- MediWound's EscharEx® Outshines Collagenase in Healing Trials
- Humacyte Reports Impressive Growth and New Market Launch Updates
- FAVO Capital Enhances Equity Structure Ahead of Nasdaq Listing
- NeuroOne's Q2 Results Show Remarkable Growth and Future Potential
- Exciting Updates on Stardust Power's Lithium Processing Plans
- Minerva Neurosciences Shares Financial Results and Updates
- Unisync's Q2 2025 Report Highlights Growth in Profitability
- Achieve Life Sciences: Big Steps Towards FDA Approval of Cytisinicline
- Knight Therapeutics to Showcase Innovations at Upcoming Conference
- Maze Therapeutics Engages Investors at Major BioConnect Event
- First Participant Dosed in ACT-EARLY Study of Acoramidis
- BrainsWay's Impressive Q1 2025 Results Boost Growth Prospects
- Anavex Life Sciences Reports Q2 FY 2025 Financial Highlights
- Caliber Hospitality Development Expands Horizons for Growth
- Bicara Therapeutics Business Highlights and Q1 2025 Financial Review
- Mereo BioPharma's 2025 Highlights and Financial Overview Revealed
- Intuitive Machines Exceeds Expectations in Q1 2025 Results
- Jones Soda Unveils Creative Collaboration with Crayola Colors
- Akadeum Enhances Microbubble Technology for Cell Therapy
- V2X Secures U.S. Army Contract for Advanced Training Systems
- MediPharm Labs Provides Insights on Corporate Strategy for Shareholders
- Duchesnay USA Teams Up with MyMenopauseRx for Women's Health
- Purple Pepe Revolutionizes Real Estate Transactions with Crypto
- Wayfair's Fun Chair-Ades Challenge Featuring Blake Griffin
- Alpha Omega Appoints Eric Laychock as Chief Operating Officer
- QinetiQ US Secures $54.3 Million for U.S. Army AI Project
- Bluefors Appoints Kim Povlsen as New CEO to Drive Growth
- VuSpex Partners with Tyler Technologies for Virtual Inspections
- Pacific Financial Group Takes Bold Steps to Lower Investor Fees
- Bluefors Appoints Kim Povlsen as New CEO to Drive Innovation
- Innovative Approach to Fumed Silica Production by PyroGenesis
- NMD Pharma Showcases Breakthrough Research in Myasthenia Gravis
- Revolutionizing Pet Care: The AI-Powered Future of Pet Health
- Celebrating AANHPI Heritage Month: Sabio's Commitment to Diversity
- Discovering the Impact of the Blockchain Futurist Conference
- Exciting New Campaign by Keeper Security Featuring Carlos Sainz
- Understanding Recent Transactions by Anne-Maria Salonius at Ålandsbanken
- Leap Therapeutics Shares Promising Financial Update and Progress
- Cellectar Biosciences Highlights Q1 2025 Growth and Plans